We are live on ! Find out more
VIVE

VIVEVE MED INC

Delisted

VIVE was delisted on the 18th of January, 2023.

30 hedge funds and large institutions have $26M invested in VIVEVE MED INC in 2019 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

12% less capital invested

Capital invested by funds: $29.6M → $26M (-$3.56M)

25% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 8

27% less funds holding

Funds holding: 4130 (-11)

79% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 14

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $1K

Holders
30
Holders Change
-11
Holders Change %
-26.83%
% of All Funds
0.65%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
6
Reduced
8
Closed
14
Calls
Puts
$1K
Net Calls
-$1K
Net Calls Change
+$13K

VIVE Hedge Fund Activity: Q1 2019 in Review

30 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in VIVEVE MED INC (VIVE) for Q1 2019, worth a combined $26M — down 12% from $29.6M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of VIVE and 3 opened new positions — a net loss of 11 holders — while 8 trimmed existing stakes and 6 added.

The largest buyer was Meitav Investment House, adding an estimated $243K. The largest seller was Hood River Capital Management, cutting an estimated $387K.

  • 30 institutional investors held VIVEVE MED INC (VIVE) as of Q1 2019, down from 41 in Q4 2018.
  • Funds reported $26M of VIVEVE MED INC stock for Q1 2019, down 12% quarter-over-quarter.
  • 3 funds opened new VIVEVE MED INC positions in Q1 2019 and 14 closed out, a net change of -11 holders.
  • The largest VIVEVE MED INC buyer in Q1 2019 was Meitav Investment House, an estimated $243K added.
  • The largest VIVEVE MED INC seller in Q1 2019 was Hood River Capital Management, an estimated $387K sold.

Based on aggregated 13F filings for Q1 2019.